Infectious Disease

Related Content

• Predicting ‘Long COVID’ At Initial Point of COVID-19 Diagnosis

   Posted on January 25, 2022

  Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.

• Maternal COVID-19 Infection Increases Risks of Preterm Birth, Low Birth Weight and Stillbirth

   Posted on January 13, 2022

  An ISB-led study examined the electronic health records of more than 18,000 people with SARS-CoV-2 tests during pregnancy, and found that those who contracted COVID-19 while pregnant were more likely to have poor birth outcomes including preterm birth, small for gestational age, low birth weight, and stillbirth. 

• 

  ISB Creates Algorithms To Accelerate Discovery of Efficacious Treatments for Tuberculosis

   Posted on December 6, 2021

  Tuberculosis (TB) is the world’s second leading infectious disease killer after COVID-19. Drug resistance to TB is a public health crisis. ISB researchers have developed algorithms to predict the efficacy of drugs in treating Mycobacterium tuberculosis (MTB), the causative agent for TB. These research findings were published in the journal Cell Reports Methods. 

• Tackling Lyme Disease with Immunity

   Posted on July 22, 2021

  It’s Lyme disease season in many areas of the United States, including the Northeast, the Midwest, and some places on the West Coast. In our latest Research Roundtable event, ISB Associate Professor Dr. Naeha Subramanian discussed the latest Lyme disease research conducted in her lab.

• How Will Healthcare and Scientific Research Be Different in a Post-Pandemic World?

   Posted on January 28, 2021

  Providence President and CEO Dr. Rod Hochman joined ISB President and Professor Dr. Jim Heath for an hour-long conversation hosted by ISB and Town Hall Seattle about how healthcare and science will be different in a post-pandemic world.

• Drs. Anthony Fauci, Lee Hood Talk COVID-19, Vaccines, Future of Research, More

   Posted on January 26, 2021

  NIAID Director Dr. Anthony Fauci sat down for a conversation with ISB’s Dr. Lee Hood. The renowned scientists spoke about the importance of basic research, the extraordinary speed of COVID research, the efficacy of mRNA vaccines on COVID-19, lessons learned from the COVID-19 pandemic, and much more.